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Background: Congenital heart defects (CHDs) are the most com-
mon forms of congenital anomalies found in humans.Prenatal
diagnosis of CHDs helps in saving the life of the baby as well as
helps in smooth transition between pre and post natal states.
Studies have shown that prenatal diagnosis improves neonatal
survival after surgical repair compared to post natal diag-
nosis.Foetal echocardiography when performed increases the rate
of detection of CHDs to 85 to 90%.
Aims: The present study is conducted to find out the incidence of
CHDs in an unselected population of pregnant women and the
association of risk factors with occurrence of CHDs.
Methods: The study subjects included all pregnant women who
attended our antenatal unit between 2008 and 2012. All women
were eligible including those without any known risk factors for
CHD. They were categorized into two groups - high risk and low
risk. Detailed fetal echocardiography was done.
Results: A total of 1280 pregnant women were included in
study.118 women had known risk factors for CHDs and were
categorized as the high risk group while remaining 1162 were
included in the low risk group. 26 cases of CHDs were detected
based on abnormal foetal echocardiography. Therefore, the inci-
dence of prenatally diagnosed CHD in our study is 20.3 per 1000.
Only 2 of the 26 cases of CHD occurred in high risk group whereas
the remaining 24 occurred in low risk pregnancy. The difference in
the incidence of CHDs between the two groups was not significant
statistically (p¼0.76). Therefore, our study shows that there is no
difference in incidence of CHDs between pregnancies associated
with high risk factors compared to low risk pregnancies.
Conclusion: Foetal echocardiography should be included as a part
of routine antenatal screening and all pregnant women should be
subjected to foetal echocardiography irrespective of risk factors
for CHDs.
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Background: Patients with significant coronary artery disease
involving left coronary system having reduced TIMI flow are
assumed to have decreased Coronary sinus flow velocity. How-
ever this has not been studied extensively in the past. The Doppler
echocardiographic evaluation of coronary sinus is required to
assess the coronary sinus flow velocity.
Aim: The aim of the study is to determine the coronary sinus flow
velocity by transthoracic echocardiography in patients with crit-
ical LAD disease and compared with patients with normal
epicardial coronaries.
Methods: 15 patients with angiographically proven LAD disease
of >70% done in the cath lab of RGGGH, Madras Medical
College, Chennai were selected for the study. The controls (15
patients) were selected from patients with normal coronaries.
The coronary sinus peak flow velocities were assessed using
Pulsewave Doppler echocardiography in parasternal long axis
inflow view.
Results: Out of the 15 CAD patients, 11 were males and 4 were
females. 6 patients had LV dysfunction with EF < 45%. All other
patients and the controls had normal LV systolic function. The
coronary sinus flow velocity in controls varies between 6.1 e 14.2
cm/s. The coronary sinus flow velocity in CAD patients varies
between 2.2- 7.4cm/s. Females were found to have decreased
coronary sinus flow velocity compared to males in both CAD pa-
tients and controls.
Conclusion: To conclude, coronary sinus flow velocity by PW
Doppler is found to be low in patients with LAD disease and can be
used as an additional marker for significant LAD disease.
Right atrial volume index and prognosis in chronic
systolic heart failure
Rajesh Das, Sougat Chakraborty, Biswajit Majumder
R.G. Kar Medical College and Hospital, Kolkata, India
Background: The ability to visualize the right atrium in echocar-
diography allows a quantitative and highly reproducible assess-
ment of the RA volume that can be indexed to body surface area to
calculate Right Atrial Volume Index (RAVI). In the ADEPT study it
was hypothesized that RA volume can serve as a quantitative
marker of RV dysfunction severity. The study concluded that in
patients with chronic systolic HF, RAVI is a determinant of right-
sided systolic dysfunction and provides independent risk predic-
tion of long-term adverse clinical events. The aim of our studywas
to see the relationship between RAVI and the prognosis in patients
with chronic systolic HF as well as to study its relationship with
different profiles i.e. age, sex, etiology of HF, NYHA functional
class, LVEF, RV systolic function.
Method: Patients between 18 to 75 years of age with LVEF of  35%
were included in this study. RA area was measured by TTE in the
apical 4-chamber view at end systole using Simpson’s method.
Clinical follow-up was for 1 year. For prognosis, the primary
endpoint was taken as the combined risk of hospitalization for
acute HF episode or death.
Results: Total 57 patients were enrolled for the study. 7 patients
were lost to follow up. Themean RAVI in our study group was 47.5
±15 ml/m2, increasing with worsening LVEF. RAVI showed no
correlation with age (p¼ 0.918), sex (p¼ 0.393) or the etiology of HF
(p¼ 0.449). In comparison to patients in NYHA class II, patients in
NYHA class III & IV has significantly high RAVI. Increased RAVI
was correlated with decreased LV systolic function as measured
by LVEF (p¼ 0.001), with decreased RV systolic function as
measured by TAPSE (p¼ 0.001) and with increased primary end-
point events (p¼ 0.005).
Conclusion: Our findings indicate that, in patients with chronic
systolic HF, the RAVI may express the severity of RV systolic
dysfunction and this quantitative echocardiographic marker can
be used to identify patients with poor prognosis.
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